Skip to main content
Top
Published in: Surgery Today 3/2024

25-10-2023 | Computed Tomography | Letter to the Editor

Could the molecular profile help predict occult nodal metastasis in early-stage lung adenocarcinoma?

Authors: Ryo Karita, Hidemi Suzuki, Yuki Onozato, Taisuke Kaiho, Terunaga Inage, Takamasa Ito, Kazuhisa Tanaka, Yuichi Sakairi, Ichiro Yoshino

Published in: Surgery Today | Issue 3/2024

Login to get access

Excerpt

Thank you for your correspondence pertaining to our manuscript. As you astutely observed, a pivotal facet of this investigation lies in its demonstration of the potential for prognosticating occult lymph node metastasis (OLM) solely through preoperative computed tomography (CT) findings. Previous reports posited that carcinoembryonic antigen (CEA) and the maximum standardized uptake (SUVmax) derived from 18F-fluorodeoxyglucose positron emission tomography combined with CT (PET-CT) might serve as predictive indicators of OLM [1, 2]. Nevertheless, our study demonstrates that preoperative CT is able to anticipate OLM even when performed alone. We posit that the findings of this study carry substantial validity, particularly considering the likelihood that a multitude of cases globally, especially in resource-constrained regions, rely exclusively upon CT to inform surgical indications. …
Literature
1.
go back to reference Ye Bo, Cheng M, Li W, Ge X-X, Geng J-F, Feng J, et al. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann Thorac Surg. 2014;98:217–23.CrossRefPubMed Ye Bo, Cheng M, Li W, Ge X-X, Geng J-F, Feng J, et al. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann Thorac Surg. 2014;98:217–23.CrossRefPubMed
2.
go back to reference Huang Miao, Li Shaolei, Li Nan, Lai Yumei, Zhang Shanyuan, Lu Fangliang, et al. Occult mediastinal lymph node metastasis in FDG‐PET/CT node‐negative lung adenocarcinoma patients: Risk factors and histopathological study. Thoracic Cancer 2019; 10:1453-1460 Huang Miao, Li Shaolei, Li Nan, Lai Yumei, Zhang Shanyuan, Lu Fangliang, et al. Occult mediastinal lymph node metastasis in FDG‐PET/CT node‐negative lung adenocarcinoma patients: Risk factors and histopathological study. Thoracic Cancer 2019; 10:1453-1460
3.
go back to reference Wakelee H, Liberman M, Kato T, Tsuboi M, Lee S-H, Gao S, et al. Perioperative pembrolizumab for early-stage non–small-cell lung cancer. N Engl J Med. 2023;389:491–503.CrossRefPubMed Wakelee H, Liberman M, Kato T, Tsuboi M, Lee S-H, Gao S, et al. Perioperative pembrolizumab for early-stage non–small-cell lung cancer. N Engl J Med. 2023;389:491–503.CrossRefPubMed
4.
go back to reference Patrick M. Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med 2022; 386:1973–85. Patrick M. Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med 2022; 386:1973–85.
Metadata
Title
Could the molecular profile help predict occult nodal metastasis in early-stage lung adenocarcinoma?
Authors
Ryo Karita
Hidemi Suzuki
Yuki Onozato
Taisuke Kaiho
Terunaga Inage
Takamasa Ito
Kazuhisa Tanaka
Yuichi Sakairi
Ichiro Yoshino
Publication date
25-10-2023
Publisher
Springer Nature Singapore
Published in
Surgery Today / Issue 3/2024
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02762-1

Other articles of this Issue 3/2024

Surgery Today 3/2024 Go to the issue